China Shineway Pharmaceutical Group Ltd ADR (CSWYY)
China Shineway Pharmaceutical Group Ltd is a depositary receipt listed on OTC Markets, tied to China Shineway Pharmaceutical Group Limited. The issuer is an investment holding company focused on the research, production, and trading of Chinese pharmaceutical products in mainland China and Hong Kong. Its portfolio includes medicines distributed in forms such as injections, soft capsules, granules, tablets, pills, oral liquids, and powders, along with traditional Chinese medicine granules used across therapeutic areas including respiratory, nervous system, digestive, cardiovascular and cerebrovascular, orthopedics, and pediatrics. The company also trades agricultural products. Incorporated in 2002 and headquartered in Shijiazhuang, China, the issuer is a subsidiary of Forway Investment Limited.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-CSWY.Y
|
$22.85
|
18.7% Upside
|
Undervalued
|
—
|
—
|
—
|
Great
|
—
|
—
|
1.42
|
13.1%
|
—
|
5.8x
|
0.7x
|
1.8x
|
803.4 M
|
-209 M
|
5.4%
|
27.4%
|
13.5
|
37.4%
|
102.5%
|
